273 related articles for article (PubMed ID: 16132517)
21. Adrenocortical carcinoma in a female infant: a case report.
García E; Cordero Gallardo G; Lugo-Vicente H
Bol Asoc Med P R; 2013; 105(4):52-5. PubMed ID: 25154176
[TBL] [Abstract][Full Text] [Related]
22. MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma.
Pereira SS; Monteiro MP; Bourdeau I; Lacroix A; Pignatelli D
Eur J Endocrinol; 2018 Aug; 179(2):R95-R110. PubMed ID: 29773584
[TBL] [Abstract][Full Text] [Related]
23. Adrenocortical carcinoma with delayed cutaneous metastasis.
Satter EK; Barnette DJ
J Cutan Pathol; 2008 Jul; 35(7):677-80. PubMed ID: 18201231
[TBL] [Abstract][Full Text] [Related]
24. Adrenocortical carcinoma: the range of appearances on CT and MRI.
Bharwani N; Rockall AG; Sahdev A; Gueorguiev M; Drake W; Grossman AB; Reznek RH
AJR Am J Roentgenol; 2011 Jun; 196(6):W706-14. PubMed ID: 21606258
[TBL] [Abstract][Full Text] [Related]
25. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
26. Non-androgen secreting adrenocortical carcinoma in preadolescence: a case report and literature review.
Narumi H; Hasegawa S; Waki K; Fukuda K; Ohnishi Y; Ichimura T; Fujimoto Y; Katsura S; Kawano H; Ikeda E; Okada S; Ohga S
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1313-1317. PubMed ID: 27771624
[TBL] [Abstract][Full Text] [Related]
27. Intensive chemotherapy with autologous PBSCT for advanced adrenocortical carcinoma in a child.
Hah JO
J Pediatr Hematol Oncol; 2008 Apr; 30(4):332-4. PubMed ID: 18391707
[TBL] [Abstract][Full Text] [Related]
28. Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab.
Casey RT; Giger O; Seetho I; Marker A; Pitfield D; Boyle LH; Gurnell M; Shaw A; Tischkowitz M; Maher ER; Chatterjee VK; Janowitz T; Mells G; Corrie P; Challis BG
Semin Oncol; 2018 Jun; 45(3):151-155. PubMed ID: 30262398
[TBL] [Abstract][Full Text] [Related]
29. Adrenocortical Carcinoma: A Clinician's Perspective.
Elfiky A
Surg Pathol Clin; 2015 Dec; 8(4):751-4. PubMed ID: 26612225
[TBL] [Abstract][Full Text] [Related]
30. Current Status and Future Targeted Therapy in Adrenocortical Cancer.
Alyateem G; Nilubol N
Front Endocrinol (Lausanne); 2021; 12():613248. PubMed ID: 33732213
[TBL] [Abstract][Full Text] [Related]
31. Myxoid adrenal cortical carcinoma presenting as primary hyperaldosteronism: case report and review of the literature.
Hsieh MS; Chen JH; Lin LW
Int J Surg Pathol; 2011 Dec; 19(6):803-7. PubMed ID: 20444728
[TBL] [Abstract][Full Text] [Related]
32. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinoma.
Pacella CM; Stasi R; Bizzarri G; Pacella S; Graziano FM; Guglielmi R; Papini E
Eur J Radiol; 2008 Apr; 66(1):88-94. PubMed ID: 17498906
[TBL] [Abstract][Full Text] [Related]
34. [The adrenocortical carcinoma, a tumour of wide clinical diversity].
Schreinemakers JM; van Dam PS; Seldenrijk CA; Biesma DH; Borel Rinkes IH
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2109-13. PubMed ID: 15553352
[TBL] [Abstract][Full Text] [Related]
35. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
36. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports.
Ko YL; Kumar V; Lippert J; Diaz-Cano S; Skordilis K; Kimpel O; Kircher S; Asia M; Elhassan YS; Altieri B; Ronchi CL
BMC Endocr Disord; 2023 Jan; 23(1):4. PubMed ID: 36604647
[TBL] [Abstract][Full Text] [Related]
37. Adrenocortical carcinoma in a 17th-century girl.
Else T; Auchus RJ; Miller WL
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):109-113. PubMed ID: 26960202
[TBL] [Abstract][Full Text] [Related]
38. Metastatic adrenal cortical carcinoma to T12 vertebrae.
Lee D; Yanamadala V; Shankar GM; Shin JH
J Clin Neurosci; 2016 May; 27():166-9. PubMed ID: 26765762
[TBL] [Abstract][Full Text] [Related]
39. In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures
Fragni M; Palma Lopez LP; Rossini E; Abate A; Cosentini D; Salvi V; Vezzoli S; Poliani PL; Bosisio D; Hantel C; Tiberio GAM; Grisanti S; Memo M; Terzolo M; Berruti A; Sigala S
Mol Cell Endocrinol; 2019 Dec; 498():110585. PubMed ID: 31536779
[TBL] [Abstract][Full Text] [Related]
40. A case of adrenocortical carcinoma accompanying secondary acute adrenal hypofunction postoperation.
Kou K; Zhang H; Zhang C; Xie E; Chen Y; Wang G; Lv G
World J Surg Oncol; 2018 Mar; 16(1):43. PubMed ID: 29506536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
